| Year | Citation | Score | |||
|---|---|---|---|---|---|
| 2022 | Kirpotin DB, Hayes ME, Noble CO, Huang ZR, Wani K, Moore D, Kesper K, Brien DO, Drummond DC. Drug Stability and Minimized Acid-/Drug-Catalyzed Phospholipid Degradation in Liposomal Irinotecan. Journal of Pharmaceutical Sciences. PMID 36462709 DOI: 10.1016/j.xphs.2022.11.025 | 0.662 | |||
| 2019 | Huang ZR, Tipparaju SK, Kirpotin DB, Pien C, Kornaga T, Noble CO, Koshkaryev A, Tran J, Kamoun WS, Drummond DC. Formulation optimization of an ephrin A2 targeted immunoliposome encapsulating reversibly modified taxane prodrugs. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 31400383 DOI: 10.1016/J.Jconrel.2019.08.006 | 0.68 | |||
| 2019 | Kamoun WS, Kirpotin DB, Huang ZR, Tipparaju SK, Noble CO, Hayes ME, Luus L, Koshkaryev A, Kim J, Olivier K, Kornaga T, Oyama S, Askoxylakis V, Pien C, Kuesters G, et al. Antitumour activity and tolerability of an EphA2-targeted nanotherapeutic in multiple mouse models. Nature Biomedical Engineering. 3: 264-280. PMID 30952988 DOI: 10.1038/S41551-019-0385-4 | 0.69 | |||
| 2018 | Tang J, Srinivasan S, Yuan W, Ming R, Liu Y, Dai Z, Noble CO, Hayes ME, Zheng N, Jiang W, Szoka FC, Schwendeman A. Development of a flow-through USP 4 apparatus drug release assay for the evaluation of amphotericin B liposome. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 30481559 DOI: 10.1016/J.Ejpb.2018.11.010 | 0.383 | |||
| 2017 | Louis N, Liu S, He X, Drummond DC, Noble CO, Goldman S, Mueller S, Bankiewicz K, Gupta N, Hashizume R. New therapeutic approaches for brainstem tumors: a comparison of delivery routes using nanoliposomal irinotecan in an animal model. Journal of Neuro-Oncology. PMID 29170909 DOI: 10.1007/S11060-017-2681-8 | 0.709 | |||
| 2017 | Clarke JL, Molinaro AM, Cabrera JR, DeSilva AA, Rabbitt JE, Prey J, Drummond DC, Kim J, Noble C, Fitzgerald JB, Chang SM, Butowski NA, Taylor JW, Park JW, Prados MD. A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade glioma. Cancer Chemotherapy and Pharmacology. PMID 28233053 DOI: 10.1200/Jco.2015.33.15_Suppl.2029 | 0.677 | |||
| 2016 | Yuan W, Kuai R, Dai Z, Yuan Y, Zheng N, Jiang W, Noble C, Hayes M, Szoka FC, Schwendeman A. Development of a Flow-Through USP-4 Apparatus Drug Release Assay to Evaluate Doxorubicin Liposomes. The Aaps Journal. PMID 27485642 DOI: 10.1208/S12248-016-9958-2 | 0.351 | |||
| 2016 | Kirpotin DB, Tipparaju S, Huang ZR, Kamoun WS, Pien C, Kornaga T, Oyama S, Olivier K, Marks JD, Koshkaryev A, Schihl SS, Fetterly G, Schoeberl B, Noble C, Hayes M, et al. Abstract 3912: MM-310, a novel EphA2-targeted docetaxel nanoliposome Cancer Research. 76: 3912-3912. DOI: 10.1158/1538-7445.Am2016-3912 | 0.683 | |||
| 2014 | Noble CO, Krauze MT, Drummond DC, Forsayeth J, Hayes ME, Beyer J, Hadaczek P, Berger MS, Kirpotin DB, Bankiewicz KS, Park JW. Pharmacokinetics, tumor accumulation and antitumor activity of nanoliposomal irinotecan following systemic treatment of intracranial tumors. Nanomedicine (London, England). 9: 2099-108. PMID 24494810 DOI: 10.2217/Nnm.13.201 | 0.652 | |||
| 2013 | Weng KC, Hashizume R, Noble CO, Serwer LP, Drummond DC, Kirpotin DB, Kuwabara AM, Chao LX, Chen FF, James CD, Park JW. Convection-enhanced delivery of targeted quantum dot-immunoliposome hybrid nanoparticles to intracranial brain tumor models. Nanomedicine (London, England). 8: 1913-25. PMID 23631502 DOI: 10.2217/Nnm.12.209 | 0.663 | |||
| 2012 | Reynolds JG, Geretti E, Hendriks BS, Lee H, Leonard SC, Klinz SG, Noble CO, Lücker PB, Zandstra PW, Drummond DC, Olivier KJ, Nielsen UB, Niyikiza C, Agresta SV, Wickham TJ. HER2-targeted liposomal doxorubicin displays enhanced anti-tumorigenic effects without associated cardiotoxicity. Toxicology and Applied Pharmacology. 262: 1-10. PMID 22676972 DOI: 10.1016/J.Taap.2012.04.008 | 0.652 | |||
| 2012 | Kirpotin DB, Noble CO, Hayes ME, Huang Z, Kornaga T, Zhou Y, Nielsen UB, Marks JD, Drummond DC. Building and characterizing antibody-targeted lipidic nanotherapeutics. Methods in Enzymology. 502: 139-66. PMID 22208985 DOI: 10.1016/B978-0-12-416039-2.00007-0 | 0.686 | |||
| 2011 | Serwer LP, Noble CO, Michaud K, Drummond DC, Kirpotin DB, Ozawa T, Prados MD, Park JW, James CD. Investigation of intravenous delivery of nanoliposomal topotecan for activity against orthotopic glioblastoma xenografts. Neuro-Oncology. 13: 1288-95. PMID 21954443 DOI: 10.1093/Neuonc/Nor139 | 0.705 | |||
| 2011 | Pavel H, Ajeawung N, Faure R, Poirier D, Kamnasaran D, Ajeawung N, Joshi H, Kamnasaran D, Poirier D, Ajeawung N, Kamnasaran D, Lun X, Zemp F, Sun B, Stechishin O, ... ... Noble CO, et al. PRECLINICAL EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY Neuro-Oncology. 13: iii107-iii120. DOI: 10.1093/Neuonc/Nor158 | 0.602 | |||
| 2010 | Dickinson PJ, LeCouteur RA, Higgins RJ, Bringas JR, Larson RF, Yamashita Y, Krauze MT, Forsayeth J, Noble CO, Drummond DC, Kirpotin DB, Park JW, Berger MS, Bankiewicz KS. Canine spontaneous glioma: a translational model system for convection-enhanced delivery. Neuro-Oncology. 12: 928-40. PMID 20488958 DOI: 10.1093/Neuonc/Noq046 | 0.681 | |||
| 2010 | Drummond DC, Noble CO, Guo Z, Hayes ME, Connolly-Ingram C, Gabriel BS, Hann B, Liu B, Park JW, Hong K, Benz CC, Marks JD, Kirpotin DB. Development of a highly stable and targetable nanoliposomal formulation of topotecan. Journal of Controlled Release : Official Journal of the Controlled Release Society. 141: 13-21. PMID 19686789 DOI: 10.1016/J.Jconrel.2009.08.006 | 0.686 | |||
| 2009 | Noble CO, Guo Z, Hayes ME, Marks JD, Park JW, Benz CC, Kirpotin DB, Drummond DC. Characterization of highly stable liposomal and immunoliposomal formulations of vincristine and vinblastine. Cancer Chemotherapy and Pharmacology. 64: 741-51. PMID 19184019 DOI: 10.1007/S00280-008-0923-3 | 0.694 | |||
| 2009 | Drummond DC, Noble CO, Guo Z, Hayes ME, Park JW, Ou CJ, Tseng YL, Hong K, Kirpotin DB. Improved pharmacokinetics and efficacy of a highly stable nanoliposomal vinorelbine. The Journal of Pharmacology and Experimental Therapeutics. 328: 321-30. PMID 18948499 DOI: 10.1124/Jpet.108.141200 | 0.71 | |||
| 2008 | Weng KC, Noble CO, Papahadjopoulos-Sternberg B, Chen FF, Drummond DC, Kirpotin DB, Wang D, Hom YK, Hann B, Park JW. Targeted tumor cell internalization and imaging of multifunctional quantum dot-conjugated immunoliposomes in vitro and in vivo. Nano Letters. 8: 2851-7. PMID 18712930 DOI: 10.1021/Nl801488U | 0.636 | |||
| 2008 | Dickinson PJ, LeCouteur RA, Higgins RJ, Bringas JR, Roberts B, Larson RF, Yamashita Y, Krauze M, Noble CO, Drummond D, Kirpotin DB, Park JW, Berger MS, Bankiewicz KS. Canine model of convection-enhanced delivery of liposomes containing CPT-11 monitored with real-time magnetic resonance imaging: laboratory investigation. Journal of Neurosurgery. 108: 989-98. PMID 18447717 DOI: 10.3171/Jns/2008/108/5/0989 | 0.664 | |||
| 2008 | Drummond DC, Noble CO, Hayes ME, Park JW, Kirpotin DB. Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development. Journal of Pharmaceutical Sciences. 97: 4696-740. PMID 18351638 DOI: 10.1002/Jps.21358 | 0.681 | |||
| 2008 | Krauze MT, Vandenberg SR, Yamashita Y, Saito R, Forsayeth J, Noble C, Park J, Bankiewicz KS. Safety of real-time convection-enhanced delivery of liposomes to primate brain: a long-term retrospective. Experimental Neurology. 210: 638-44. PMID 18295759 DOI: 10.1016/J.Expneurol.2007.12.015 | 0.371 | |||
| 2007 | Krauze MT, Noble CO, Kawaguchi T, Drummond D, Kirpotin DB, Yamashita Y, Kullberg E, Forsayeth J, Park JW, Bankiewicz KS. Convection-enhanced delivery of nanoliposomal CPT-11 (irinotecan) and PEGylated liposomal doxorubicin (Doxil) in rodent intracranial brain tumor xenografts. Neuro-Oncology. 9: 393-403. PMID 17652269 DOI: 10.1215/15228517-2007-019 | 0.735 | |||
| 2007 | Yamashita Y, Krauze MT, Kawaguchi T, Noble CO, Drummond DC, Park JW, Bankiewicz KS. Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts. Neuro-Oncology. 9: 20-8. PMID 17018695 DOI: 10.1215/15228517-2006-016 | 0.699 | |||
| 2007 | Bankiewicz KS, Krauze M, Saito R, Yamashita Y, Noble C, Bringas J, Park J, LeCouteur R, Higgins R, Dickinson P. 8. Use of Real-Time MR Imaging for CED of Nano-particles for Treatment of Brain Tumors(Part 3:Stereotactic surgery, PS2-1 Current Status and Evolution of Multimodality Treatment, The 27^ | Annual Meeting of The Japanese Congress of Neurological Surgeons) Japanese Journal of Neurosurgery. 16: 318. DOI: 10.7887/Jcns.16.318_1 | 0.324 | ||
| 2006 | Saito R, Krauze MT, Noble CO, Drummond DC, Kirpotin DB, Berger MS, Park JW, Bankiewicz KS. Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model. Neuro-Oncology. 8: 205-14. PMID 16723630 DOI: 10.1215/15228517-2006-001 | 0.693 | |||
| 2006 | Hadaczek P, Yamashita Y, Mirek H, Tamas L, Bohn MC, Noble C, Park JW, Bankiewicz K. The "perivascular pump" driven by arterial pulsation is a powerful mechanism for the distribution of therapeutic molecules within the brain. Molecular Therapy : the Journal of the American Society of Gene Therapy. 14: 69-78. PMID 16650807 DOI: 10.1016/J.Ymthe.2006.02.018 | 0.31 | |||
| 2006 | Drummond DC, Noble CO, Guo Z, Hong K, Park JW, Kirpotin DB. Development of a highly active nanoliposomal irinotecan using a novel intraliposomal stabilization strategy. Cancer Research. 66: 3271-7. PMID 16540680 DOI: 10.1158/0008-5472.Can-05-4007 | 0.705 | |||
| 2006 | Noble CO, Krauze MT, Drummond DC, Yamashita Y, Saito R, Berger MS, Kirpotin DB, Bankiewicz KS, Park JW. Novel nanoliposomal CPT-11 infused by convection-enhanced delivery in intracranial tumors: pharmacology and efficacy. Cancer Research. 66: 2801-6. PMID 16510602 DOI: 10.1158/0008-5472.Can-05-3535 | 0.671 | |||
| 2006 | Saito R, Krauze MT, Noble CO, Tamas M, Drummond DC, Kirpotin DB, Berger MS, Park JW, Bankiewicz KS. Tissue affinity of the infusate affects the distribution volume during convection-enhanced delivery into rodent brains: implications for local drug delivery. Journal of Neuroscience Methods. 154: 225-32. PMID 16472868 DOI: 10.1016/J.Jneumeth.2005.12.027 | 0.661 | |||
| 2006 | Hayes ME, Drummond DC, Kirpotin DB, Zheng WW, Noble CO, Park JW, Marks JD, Benz CC, Hong K. Genospheres: self-assembling nucleic acid-lipid nanoparticles suitable for targeted gene delivery. Gene Therapy. 13: 646-51. PMID 16341056 DOI: 10.1038/Sj.Gt.3302699 | 0.611 | |||
| 2006 | Yamashita Y, Saito R, Krauze MT, Kawaguchi T, Noble C, Drummond DC, Kirpotin DB, Park JW, Berger MS, Bankiewicz KS. Convection-enhanced delivery of liposomal doxorubicin in intracranial brain tumor xenografts Targeted Oncology. 1: 79-85. DOI: 10.1007/S11523-006-0011-8 | 0.706 | |||
| 2005 | Mamot C, Drummond DC, Noble CO, Kallab V, Guo Z, Hong K, Kirpotin DB, Park JW. Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo. Cancer Research. 65: 11631-8. PMID 16357174 DOI: 10.1158/0008-5472.Can-05-1093 | 0.707 | |||
| 2005 | Krauze MT, Saito R, Noble C, Tamas M, Bringas J, Park JW, Berger MS, Bankiewicz K. Reflux-free cannula for convection-enhanced high-speed delivery of therapeutic agents. Journal of Neurosurgery. 103: 923-9. PMID 16304999 DOI: 10.3171/Jns.2005.103.5.0923 | 0.367 | |||
| 2005 | Saito R, Krauze MT, Bringas JR, Noble C, McKnight TR, Jackson P, Wendland MF, Mamot C, Drummond DC, Kirpotin DB, Hong K, Berger MS, Park JW, Bankiewicz KS. Gadolinium-loaded liposomes allow for real-time magnetic resonance imaging of convection-enhanced delivery in the primate brain. Experimental Neurology. 196: 381-9. PMID 16197944 DOI: 10.1016/J.Expneurol.2005.08.016 | 0.704 | |||
| 2005 | Krauze MT, Mcknight TR, Yamashita Y, Bringas J, Noble CO, Saito R, Geletneky K, Forsayeth J, Berger MS, Jackson P, Park JW, Bankiewicz KS. Real-time visualization and characterization of liposomal delivery into the monkey brain by magnetic resonance imaging. Brain Research. Brain Research Protocols. 16: 20-6. PMID 16181805 DOI: 10.1016/J.Brainresprot.2005.08.003 | 0.458 | |||
| 2005 | Krauze MT, Saito R, Noble C, Bringas J, Forsayeth J, McKnight TR, Park J, Bankiewicz KS. Effects of the perivascular space on convection-enhanced delivery of liposomes in primate putamen. Experimental Neurology. 196: 104-11. PMID 16109410 DOI: 10.1016/J.Expneurol.2005.07.009 | 0.457 | |||
| 2005 | Drummond DC, Marx C, Guo Z, Scott G, Noble C, Wang D, Pallavicini M, Kirpotin DB, Benz CC. Enhanced pharmacodynamic and antitumor properties of a histone deacetylase inhibitor encapsulated in liposomes or ErbB2-targeted immunoliposomes. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 3392-401. PMID 15867240 DOI: 10.1158/1078-0432.Ccr-04-2445 | 0.685 | |||
| 2005 | Drummond DC, Noble CO, Kirpotin DB, Guo Z, Scott GK, Benz CC. Clinical development of histone deacetylase inhibitors as anticancer agents. Annual Review of Pharmacology and Toxicology. 45: 495-528. PMID 15822187 DOI: 10.1146/Annurev.Pharmtox.45.120403.095825 | 0.617 | |||
| 2004 | Noble CO, Kirpotin DB, Hayes ME, Mamot C, Hong K, Park JW, Benz CC, Marks JD, Drummond DC. Development of ligand-targeted liposomes for cancer therapy. Expert Opinion On Therapeutic Targets. 8: 335-53. PMID 15268628 DOI: 10.1517/14728222.8.4.335 | 0.637 | |||
| 2001 | McCarley TD, Noble CO, DuBois CJ, McCarley RL. MALDI-MS evaluation of poly(3-hexylthiophene) synthesized by chemical oxidation with FeCl3 Macromolecules. 34: 7999-8004. DOI: 10.1021/Ma002140Z | 0.473 | |||
| Show low-probability matches. | |||||